This June, experts in the Life Sciences industry gathered in Milan to participate in a workshop on “Industry 4.0: The New Challenges for Project Planning and Oversight in the Life Sciences Industry”. The workshop was a result of joint efforts between our Arithmos team and LS Academy and was organszed in order to peek into changes triggered by Industry 4.0.
Industry 4.0 is a recent concept that encompasses all the processes of automatisations and emerging cyber-physical systems in different industries. Life Science is among the areas most affected by these changes due to its willingness to adopt new technologies and its responsiveness to new trends. During our workshop, we covered different aspects of the Life Sciences industry that are affected by Industry 4.0.
We have invited a number of Key Opinion Leaders from the Pharma and Life Sciences fields to share their experience and ideas on Industry 4.0. Here are the topics they have covered during the workshop:
- IoT and Big Data: advantages and opportunities of eHealth technologies in Life Sciences Sector.
- Speaker: Paolo Morelli, CEO & Owner of PM Holding;
- New challenges for Human Resources in Industry 4.0: Management time planning research results and their structure.
- Speaker: Roberto Bugatti, Partner of VisAlta Consulting;
- Sponsor Oversight Management: Effective use of third party technology.
- Speaker: Heike Schoen, Managing Director and Co-Founder at LUMIS International GmbH;
- New model of Industry 4.0: Altea UP. Instruments and technologie for the pharma process governance.
- Speaker: Pierluigi De Rosa, Solution Leader Chemical & Lifescience at Altea UP;
- Implementation strategy of ClinOps system: challenges and choices.
- Speaker: Daniele Segagni, Group ICT Global Business Process and Application Specialist, Chiesi Group
- How new technologies are changing patient relations: from the SEO era to IA and chatbot.
- Speaker: Matteo Nicolosi, Web Content Developer at Istituto Clinico Humanitas;
- How intelligent automation is reshaping the workforce landscape.
- Speaker: Andrea Melison, Senior Manager Business Service at KPMG Italy.
Best quotes of the workshop
“Blending IoT, Big Data and AI in clinical trials processes can greatly improve the competitiveness of CROs and Pharma/Medical Companies, while at the same time lowering the costs of clinical research and facilitation the invention and validation of new medical products and services that will revolutionize healthcare in the years to come.”Paolo Morelli, CEO & Owner of PM Holding
“Digital revolution has positive effect if it helps employers to compress time needed for standardized activities and relocate it to work activities that require non-standard approach.”Roberto Bugatti, Partner of VisAlta Consulting
“Company should set adequate extended and shared IT Governance structure, which ensures that the company data is managed correctly.”Pierluigi De Rosa, Solution Leader Chemical & Lifescience at Altea UP
“Real-World Evidence could be used from R&D departments to support regulatory submissions for additional drug indications and to inform new drug development.”Daniele Segagni, Group ICT Global Business Process and Application Specialist, Chiesi Group
“Robotic Process Automation and digital labor can be scaled much more quickly and cost effectively than traditional IT implementations.”Andrea Melison, Senior Manager Business Service at KPMG Italy